REG - ValiRx PLC - Change of Adviser <Origin Href="QuoteRef">VALX.L</Origin>
RNS Number : 9995OValiRx PLC03 June 20153 June 2015
ValiRx Plc
('ValiRx' or the 'Company')
Change of Adviser
London, UK, 3 June 2015 - ValiRx Plc (AIM: VAL), a life science company with a focus on cancer therapeutics and diagnostics for personalised medicine, announces that Northland Capital Partners Limited has been appointed sole broker to the Company with immediate effect.
ValiRx Plc
Tel: +44 (0)20 3008 4416
Dr Satu Vainikka
Cairn Financial Advisers LLP (Nominated Adviser)
Tel: +44 (0)20 7148 7900
Liam Murray / Avi Robinson
Northland Capital Partners Limited (Broker)
Tel: +44 (0)20 7382 1100
Patrick Claridge / John Howes / Abigail Wayne
Peckwater PR
Tel: +44 (0)7879 458 364
Tarquin Edwards
This information is provided by RNSThe company news service from the London Stock ExchangeENDAPPFMGGVKZMGKZM
Recent news on ValiRx
See all newsREG - ValiRx PLC - Directorate Changes
AnnouncementREG - ValiRx PLC - Evaluation Agreement with Imperial College London
AnnouncementREG - ValiRx PLC - Board Re-structuring and update on requisition
AnnouncementREG - ValiRx PLC - Shareholder Requisition Notice
AnnouncementREG - ValiRx PLC - Proposed Appointment of Non-Executive Director
Announcement